Market Research Report
Europe Blood Market Forecast 2019-2028
|Published by||Inkwood Research||Product code||952504|
|Published||Content info||128 Pages
Delivery time: 2-3 business days
|Europe Blood Market Forecast 2019-2028|
|Published: August 3, 2020||Content info: 128 Pages||
The Europe blood market is anticipated to register a CAGR of 3.82%, across the forecast years of 2019 to 2028. Factors that promote market growth comprise the upsurge in widespread blood testing and blood screening due to the coronavirus pandemic.
The Europe blood market growth is analyzed through the United Kingdom, Russia, Italy, Poland, Belgium, Germany, France, and the rest of Europe. Italy's blood market is depicting high growth as a result of rapid blood tests conducted during the COVID-19 pandemic. The blood system in the country is a part of the National Health Service. Thus, health care services, including blood and blood component collection, testing, processing, storage, distribution, and transfusion medicine, are delivered by the Regional Health Services, within the national legislative framework. These services define the Ministry of Health's functions, like, coordination, legislation, and supervision.
In Belgium, the spread of the coronavirus has plummeted the country's stocks, due to the cancellation of blood drive events and reduced mobility of would-be-donors. According to health organizations, these events are being called off to minimize the movement of workers and encouraging them to work from home. As a result, the initiative has significantly reduced critical supplies. Thus, the demand for blood screening techniques, and the surge in preventative measures for using blood for transfusion, is projected to bolster the region's market growth.
Major companies operating in the market include, Novo Nordisk A/S, CSL Limited (CSL Behring), Baxter International Inc, Beckton, Dickinson, and Company, Immucor Inc, etc.